Back to Search
RICHARD O'DONNELL, M.D.,D.D.S.
M.D.,D.D.S.
Specialist
NPI: 1144355967Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD).
PMID 19306119·Invest New Drugs·2010
8-other
Compressive osseointegration of tibial implants in primary cancer reconstruction.
PMID 19653050·Clin Orthop Relat Res·2009
8-other
Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenografts.
PMID 19437017·Cancer Immunol Immunother·2009
7-preclinical
Phosphatase inhibition augments anti-CD22-mediated signaling and cytotoxicity in non-hodgkin's lymphoma cells.
PMID 19237192·Leuk Res·2009
8-other
Treatment of non-Hodgkin's lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy.
PMID 19294384·Cancer Immunol Immunother·2009
7-preclinical
Immunohistochemical method identifies lymphovascular invasion in a majority of oral squamous cell carcinomas and discriminates between blood and lymphatic vessel invasion.
PMID 18505934·J Histochem Cytochem·2008
8-other
Experimental evidence that oral secretions of northwestern ring-necked snakes (Diadophis punctatus occidentalis) are toxic to their prey.
PMID 17689581·Toxicon·2007
7-preclinical
Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response.
PMID 17574329·Cancer Lett·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2005 FRANKLIN ST, MIDTOWN 1 SUITE 330
DENVER, CO 80205 - Phone
- (303) 860-7575
Quick Facts
- NPI
- 1144355967
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile